Cerity Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,235
| Closed | -$3.32M | – | 760 |
|
|
2020
Q4 | $3.32M | Buy |
21,235
+746
| +4% | +$117K | 0.11% | 155 |
|
|
2020
Q3 | $2.35M | Buy |
20,489
+11,603
| +131% | +$1.33M | 0.1% | 149 |
|
|
2020
Q2 | $998K | Buy |
8,886
+10
| +0.1% | +$1.12K | 0.06% | 203 |
|
|
2020
Q1 | $797K | Sell |
8,876
-2,615
| -23% | -$235K | 0.05% | 237 |
|
|
2019
Q4 | $1.24M | Sell |
11,491
-4,093
| -26% | -$443K | 0.06% | 213 |
|
|
2019
Q3 | $1.53M | Sell |
15,584
-2,018
| -11% | -$198K | 0.09% | 197 |
|
|
2019
Q2 | $2.31M | Sell |
17,602
-1,939
| -10% | -$254K | 0.15% | 141 |
|
|
2019
Q1 | $2.64M | Sell |
19,541
-87
| -0.4% | -$11.8K | 0.18% | 132 |
|
|
2018
Q4 | $1.91M | Sell |
19,628
-692
| -3% | -$67.4K | 0.13% | 161 |
|
|
2018
Q3 | $2.83M | Buy |
20,320
+554
| +3% | +$77K | 0.2% | 130 |
|
|
2018
Q2 | $2.45M | Sell |
19,766
-1,644
| -8% | -$204K | 0.18% | 133 |
|
|
2018
Q1 | $2.39M | Sell |
21,410
-2,563
| -11% | -$286K | 0.18% | 134 |
|
|
2017
Q4 | $2.87M | Sell |
23,973
-2,791
| -10% | -$334K | 0.19% | 119 |
|
|
2017
Q3 | $3.76M | Buy |
26,764
+20,084
| +301% | +$2.82M | 0.27% | 92 |
|
|
2017
Q2 | $656K | Buy |
6,680
+4,861
| +267% | +$477K | 0.05% | 206 |
|
|
2017
Q1 | $221K | Buy |
+1,819
| New | +$221K | 0.02% | 402 |
|